Morning Buzz: Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), LightPath Technologies, Inc. (NASDAQ:LPTH), KB Home (NYSE:KBH), Park Electrochemical Corp. (NYSE:PKE), GenMark Diagnostics, Inc. (NASDAQ:GNMK)

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) announced plans to change its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV), to be effective on or before August 3, 2015. Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) belongs to Healthcare sector. Its weekly performance is 5.15%. On last trading day company shares ended up $10.83. Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) distance from 50-day simple moving average (SMA50) is -13.79%.

LightPath Technologies, Inc. (NASDAQ:LPTH) expects to report revenue in the range of $4.3 million to $4.5 million for the fourth quarter of fiscal 2015, an increase of between 38% and 45%, as compared to the fourth quarter of fiscal 2014. LightPath Technologies, Inc. (NASDAQ:LPTH) shares moved up 7.36% in last trading session and ended the day at $1.75. LPTH Gross Margin is 42.30% and its return on assets is -2.80%. LightPath Technologies, Inc. (NASDAQ:LPTH) quarterly performance is 48.31%.

KB Home (NYSE:KBH), announced the grand opening of Lynbrook at The Preserve, the builder’s latest new home community within the popular Chino master plan. Following the sell-out success of its previous neighborhoods within The Preserve, KB Home plans to construct a total of 114 homes at Lynbrook. A grand opening celebration took place on Saturday, August 1. On 06 August, KB Home (NYSE:KBH) shares moved up 1.40% and was closed at $15.16. KBH EPS growth in last 5 year was 55.00%. KB Home (NYSE:KBH) year to date (YTD) performance is -7.91%.

Park Electrochemical Corp. (NYSE:PKE) ended the last trading day at $18.15. Company weekly volatility is calculated as 2.55% and price to cash ratio as 1.62. Park Electrochemical Corp. (NYSE:PKE) showed a weekly performance of 1.45%.

GenMark Diagnostics Inc. (NASDAQ:GNMK) on Thursday reported a loss of $12.2 million in its second quarter. On a per-share basis, the Carlsbad, California-based company said it had a loss of 29 cents. The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 29 cents per share. GenMark Diagnostics, Inc. (NASDAQ:GNMK) shares moved down -3.26% in last trading session and ended the day at $8.01. GNMK Gross Margin is 59.10% and its return on assets is -40.60%. GenMark Diagnostics, Inc. (NASDAQ:GNMK) quarterly performance is -14.42%.

Leave a Reply

Your email address will not be published. Required fields are marked *